TRLV
Price
$11.31
Change
-$0.01 (-0.09%)
Updated
Sep 11 closing price
Capitalization
2.18B
60 days until earnings call
Intraday BUY SELL Signals
YCBD
Price
$0.48
Change
-$0.00 (-0.00%)
Updated
Sep 11 closing price
Capitalization
5.4M
97 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

TRLV vs YCBD

TRLV vs YCBD Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
TRLV vs. YCBD commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRLV is a StrongBuy and YCBD is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRLV($2.18B) has a higher market cap than YCBD($5.4M). TRLV YTD gains are higher at: 30.150 vs. YCBD (-64.281). YCBD has higher annual earnings (EBITDA): -1.19M vs. TRLV (-99.13M). TRLV has more cash in the bank: 325M vs. YCBD (2.12M). YCBD has less debt than TRLV: YCBD (2.21M) vs TRLV (577M). TRLV has higher revenues than YCBD: TRLV (1.14B) vs YCBD (20.9M).
TRLVYCBDTRLV / YCBD
Capitalization2.18B5.4M40,311%
EBITDA-99.13M-1.19M8,328%
Gain YTD30.150-64.281-47%
P/E RatioN/A2.10-
Revenue1.14B20.9M5,450%
Total Cash325M2.12M15,345%
Total Debt577M2.21M26,085%
FUNDAMENTALS RATINGS
TRLV vs YCBD: Fundamental Ratings
TRLV
YCBD
OUTLOOK RATING
1..100
3651
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
31
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
3684
P/E GROWTH RATING
1..100
1412
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

YCBD's Valuation (31) in the Other Consumer Services industry is somewhat better than the same rating for TRLV (73) in the null industry. This means that YCBD’s stock grew somewhat faster than TRLV’s over the last 12 months.

YCBD's Profit vs Risk Rating (100) in the Other Consumer Services industry is in the same range as TRLV (100) in the null industry. This means that YCBD’s stock grew similarly to TRLV’s over the last 12 months.

YCBD's SMR Rating (97) in the Other Consumer Services industry is in the same range as TRLV (98) in the null industry. This means that YCBD’s stock grew similarly to TRLV’s over the last 12 months.

TRLV's Price Growth Rating (36) in the null industry is somewhat better than the same rating for YCBD (84) in the Other Consumer Services industry. This means that TRLV’s stock grew somewhat faster than YCBD’s over the last 12 months.

YCBD's P/E Growth Rating (12) in the Other Consumer Services industry is in the same range as TRLV (14) in the null industry. This means that YCBD’s stock grew similarly to TRLV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TRLVYCBD
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 18 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (TRLV: $11.31 vs. YCBD: $0.48)
Brand notoriety: TRLV and YCBD are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: TRLV: 135% vs. YCBD: 6%
Market capitalization -- TRLV: $2.18B vs. YCBD: $5.4M
TRLV [@Pharmaceuticals: Generic] is valued at $2.18B. YCBD’s [@Pharmaceuticals: Generic] market capitalization is $5.4M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $63.66B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TRLV’s FA Score shows that 1 FA rating(s) are green while YCBD’s FA Score has 2 green FA rating(s).

  • TRLV’s FA Score: 1 green, 4 red.
  • YCBD’s FA Score: 2 green, 3 red.
According to our system of comparison, both TRLV and YCBD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TRLV’s TA Score shows that 5 TA indicator(s) are bullish while YCBD’s TA Score has 3 bullish TA indicator(s).

  • TRLV’s TA Score: 5 bullish, 5 bearish.
  • YCBD’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both TRLV and YCBD are a good buy in the short-term.

Price Growth

TRLV (@Pharmaceuticals: Generic) experienced а -6.61% price change this week, while YCBD (@Pharmaceuticals: Generic) price change was +1.39% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -5.31%. For the same industry, the average monthly price growth was -4.84%, and the average quarterly price growth was +30.17%.

Reported Earning Dates

TRLV is expected to report earnings on Nov 11, 2026.

YCBD is expected to report earnings on Dec 18, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-5.31% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
TRLV
Daily Signal:
Gain/Loss:
YCBD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AWAY17.780.10
+0.54%
Amplify Travel Tech ETF
NUV8.720.04
+0.46%
Nuveen Municipal Value Fund
CGHY24.930.01
+0.03%
Capital Group High Yield Bond ETF
FOF12.91-0.04
-0.31%
Cohen & Steers Closed End Opportunity Fund
KURE17.74-0.06
-0.34%
KraneShares MSCI All China Hlth Care ETF

TRLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRLV has been closely correlated with GLAS. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRLV jumps, then GLAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRLV
1D Price
Change %
TRLV100%
-0.09%
GLAS - TRLV
72%
Closely correlated
-0.63%
CGC - TRLV
69%
Closely correlated
-0.25%
ACB - TRLV
65%
Loosely correlated
+0.27%
CRON - TRLV
61%
Loosely correlated
-0.63%
OGI - TRLV
54%
Loosely correlated
-1.87%
More

YCBD and

Correlation & Price change

A.I.dvisor indicates that over the last year, YCBD has been loosely correlated with GLAS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if YCBD jumps, then GLAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To YCBD
1D Price
Change %
YCBD100%
+0.88%
GLAS - YCBD
53%
Loosely correlated
-0.63%
TRLV - YCBD
50%
Loosely correlated
-0.09%
CRON - YCBD
41%
Loosely correlated
-0.63%
DERM - YCBD
24%
Poorly correlated
+1.97%
SXTC - YCBD
23%
Poorly correlated
+32.64%
More